Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.

Wasenang W, Puapairoj A, Settasatian C, Proungvitaya S, Limpaiboon T.

Pathol Res Pract. 2019 Jul;215(7):152451. doi: 10.1016/j.prp.2019.152451. Epub 2019 May 13.

PMID:
31126817
2.

Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients.

Kritmetapak K, Anutrakulchai S, Pongchaiyakul C, Puapairoj A.

Clin Kidney J. 2018 Jun;11(3):342-347. doi: 10.1093/ckj/sfx111. Epub 2017 Sep 18.

3.

Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma.

Loilome W, Kadsanit S, Muisook K, Yongvanit P, Namwat N, Techasen A, Puapairoj A, Khuntikeo N, Phonjit P.

Oncol Lett. 2017 Feb;13(2):639-646. doi: 10.3892/ol.2016.5477. Epub 2016 Dec 8.

4.

Relation of peritubular capillary features to class of lupus nephritis.

Anutrakulchai S, Titipungul T, Pattay T, Mesung P, Puapairoj A, Sirivongs D, Pongsakul C, Futrakul P, Thinkhamrop B, Johnson RJ.

BMC Nephrol. 2016 Nov 9;17(1):169.

5.

Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.

Yothaisong S, Namwat N, Yongvanit P, Khuntikeo N, Puapairoj A, Jutabha P, Anzai N, Tassaneeyakul W, Tangsucharit P, Loilome W.

Parasitol Int. 2017 Aug;66(4):471-478. doi: 10.1016/j.parint.2015.11.011. Epub 2015 Nov 30.

PMID:
26657242
6.

Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.

Sawanyawisuth K, Tantapotinan N, Wongkham C, Riggins GJ, Kraiklang R, Wongkham S, Puapairoj A.

Ann Hepatol. 2016 Jan-Feb;15(1):71-81.

7.

Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model.

Yothaisong S, Thanee M, Namwat N, Yongvanit P, Boonmars T, Puapairoj A, Loilome W.

Asian Pac J Cancer Prev. 2014;15(23):10463-8.

8.

Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy.

Seubwai W, Wongkham C, Puapairoj A, Khuntikeo N, Pugkhem A, Hahnvajanawong C, Chaiyagool J, Umezawa K, Okada S, Wongkham S.

PLoS One. 2014 Aug 29;9(8):e106056. doi: 10.1371/journal.pone.0106056. eCollection 2014.

9.

Increased EphB2 expression predicts cholangiocarcinoma metastasis.

Khansaard W, Techasen A, Namwat N, Yongvanit P, Khuntikeo N, Puapairoj A, Loilome W.

Tumour Biol. 2014 Oct;35(10):10031-41. doi: 10.1007/s13277-014-2295-0. Epub 2014 Jul 11.

PMID:
25012246
10.

Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression.

Techasen A, Namwat N, Loilome W, Duangkumpha K, Puapairoj A, Saya H, Yongvanit P.

J Hepatobiliary Pancreat Sci. 2014 Sep;21(9):703-11. doi: 10.1002/jhbp.125. Epub 2014 May 27.

PMID:
24867797
11.

Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.

Techasen A, Loilome W, Namwat N, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H, Yongvanit P.

Tumour Biol. 2014 Sep;35(9):8645-52. doi: 10.1007/s13277-014-2087-6. Epub 2014 May 28.

PMID:
24867095
12.

PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.

Jongthawin J, Chusorn P, Techasen A, Loilome W, Boonmars T, Thanan R, Puapairoj A, Khuntikeo N, Tassaneeyakul W, Yongvanit P, Namwat N.

Tumour Biol. 2014 Aug;35(8):8051-64. doi: 10.1007/s13277-014-2021-y. Epub 2014 May 18.

PMID:
24839005
13.

Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells.

Loilome W, Bungkanjana P, Techasen A, Namwat N, Yongvanit P, Puapairoj A, Khuntikeo N, Riggins GJ.

Tumour Biol. 2014 Jun;35(6):5357-67. doi: 10.1007/s13277-014-1698-2. Epub 2014 Feb 19.

14.

Association of NRF2 polymorphism with cholangiocarcinoma prognosis in Thai patients.

Khunluck T, Kukongviriyapan V, Puapairoj A, Khuntikeo N, Senggunprai L, Zeekpudsa P, Prawan A.

Asian Pac J Cancer Prev. 2014;15(1):299-304.

15.

Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.

Yothaisong S, Dokduang H, Techasen A, Namwat N, Yongvanit P, Bhudhisawasdi V, Puapairoj A, Riggins GJ, Loilome W.

Tumour Biol. 2013 Dec;34(6):3637-48. doi: 10.1007/s13277-013-0945-2. Epub 2013 Jul 6.

PMID:
23832540
16.

Palliative treatment of advanced cervical cancer with radiotherapy and thai herbal medicine as supportive remedy - analysis of survival.

Pesee M, Kirdpon W, Puapairoj A, Kirdpon S, Prathnadi P.

Asian Pac J Cancer Prev. 2013;14(3):1593-6.

17.

PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.

Loilome W, Yooyuen S, Namwat N, Sithithaworn P, Puapairoj A, Kano J, Noguchi M, Miwa M, Yongvanit P.

Tumour Biol. 2012 Dec;33(6):2289-98. doi: 10.1007/s13277-012-0491-3. Epub 2012 Aug 26.

PMID:
22922884
18.

Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma.

Techasen A, Namwat N, Loilome W, Bungkanjana P, Khuntikeo N, Puapairoj A, Jearanaikoon P, Saya H, Yongvanit P.

Med Oncol. 2012 Dec;29(5):3083-91. doi: 10.1007/s12032-012-0305-x. Epub 2012 Aug 19.

PMID:
22903530
19.

Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development.

Loilome W, Kadsanit S, Namwat N, Techasen A, Puapairoj A, Dechakhamphu A, Pinitsoontorn C, Yongvanit P.

Asian Pac J Cancer Prev. 2012;13 Suppl:59-64.

20.

NQO1 expression correlates with cholangiocarcinoma prognosis.

Buranrat B, Chau-in S, Prawan A, Puapairoj A, Zeekpudsa P, Kukongviriyapan V.

Asian Pac J Cancer Prev. 2012;13 Suppl:131-6.

21.

High expression of ABCC1 indicates poor prognosis in intrahepatic cholangiocarcinoma.

Srimunta U, Sawanyawisuth K, Kraiklang R, Pairojkul C, Puapairoj A, Titipungul T, Hahnvajanawong C, Tassaneeyakul W, Wongkham C, Wongkham S, Vaeteewoottacharn K.

Asian Pac J Cancer Prev. 2012;13 Suppl:125-30.

22.

Overexpression of O-GlcNAc-transferase associates with aggressiveness of mass-forming cholangiocarcinoma.

Phoomak C, Silsirivanit A, Wongkham C, Sripa B, Puapairoj A, Wongkham S.

Asian Pac J Cancer Prev. 2012;13 Suppl:101-5.

23.

Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma.

Boonjaraspinyo S, Boonmars T, Kaewkes S, Laummaunwai P, Pinlaor S, Loilome W, Yongvanit P, Wu Z, Puapairoj A, Bhudhisawasdi V.

Pathol Oncol Res. 2012 Apr;18(2):227-37. doi: 10.1007/s12253-011-9432-5. Epub 2011 Jul 13.

PMID:
21750953
24.

Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma.

Yongvanit P, Phanomsri E, Namwat N, Kampan J, Tassaneeyakul W, Loilome W, Puapairoj A, Khuntikeo N.

Parasitol Int. 2012 Mar;61(1):162-6. doi: 10.1016/j.parint.2011.06.026. Epub 2011 Jul 2.

PMID:
21745589
25.

Candidate genes involving in tumorigenesis of cholangiocarcinoma induced by Opisthorchis viverrini infection.

Wu Z, Boonmars T, Boonjaraspinyo S, Nagano I, Pinlaor S, Puapairoj A, Yongvanit P, Takahashi Y.

Parasitol Res. 2011 Sep;109(3):657-73. doi: 10.1007/s00436-011-2298-3. Epub 2011 Mar 5.

PMID:
21380578
26.

The first reported case of Bartonella endocarditis in Thailand.

Pachirat O, Kosoy M, Bai Y, Prathani S, Puapairoj A, Zeidner N, Peruski LF, Baggett H, Watt G, Maloney SA.

Infect Dis Rep. 2011 Jun 1;3(1):e9. doi: 10.4081/idr.2011.e9. eCollection 2011 Mar 8. Review.

27.

Involvement of c-Ski oncoprotein in carcinogenesis of cholangiocacinoma induced by Opisthorchis viverrini and N-nitrosodimethylamine.

Boonmars T, Wu Z, Boonjaruspinyo S, Puapairoj A, Kaewsamut B, Nagano I, Pinlaor S, Yongvanit P, Wonkchalee O, Juasook A, Sudsarn P, Srisawangwong T.

Pathol Oncol Res. 2011 Jun;17(2):219-27. doi: 10.1007/s12253-010-9300-8. Epub 2010 Sep 18.

PMID:
20853076
28.

PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma.

Loilome W, Juntana S, Namwat N, Bhudhisawasdi V, Puapairoj A, Sripa B, Miwa M, Saya H, Riggins GJ, Yongvanit P.

Int J Cancer. 2011 Jul 1;129(1):34-44. doi: 10.1002/ijc.25646. Epub 2010 Nov 3.

29.

Indirect effect of a turmeric diet: enhanced bile duct proliferation in Syrian hamsters with a combination of partial obstruction by Opisthorchis viverrini infection and inflammation by N-nitrosodimethylamine administration.

Boonjaraspinyo S, Boonmars T, Aromdee C, Puapairoj A, Wu Z.

Parasitol Res. 2011 Jan;108(1):7-14. doi: 10.1007/s00436-010-2031-7. Epub 2010 Sep 7.

PMID:
20821233
30.

22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.

Seubwai W, Wongkham C, Puapairoj A, Okada S, Wongkham S.

Cancer. 2010 Dec 1;116(23):5535-43. doi: 10.1002/cncr.25478. Epub 2010 Aug 2.

31.

Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB.

Seubwai W, Vaeteewoottacharn K, Hiyoshi M, Suzu S, Puapairoj A, Wongkham C, Okada S, Wongkham S.

Cancer Sci. 2010 Jul;101(7):1590-5. doi: 10.1111/j.1349-7006.2010.01572.x. Epub 2010 Mar 24.

32.

Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway.

Techasen A, Loilome W, Namwat N, Takahashi E, Sugihara E, Puapairoj A, Miwa M, Saya H, Yongvanit P.

Cancer Sci. 2010 Mar;101(3):658-65. doi: 10.1111/j.1349-7006.2009.01427.x. Epub 2009 Nov 7.

33.

Novel PNLIPRP3 and DOCK8 gene expression and prognostic implications of DNA loss on chromosome 10q25.3 in hepatocellular carcinoma.

Saelee P, Wongkham S, Puapairoj A, Khuntikeo N, Petmitr S, Chariyalertsak S, Sumethchotimaytha W, Karalak A.

Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):501-6.

34.

Turmeric reduces inflammatory cells in hamster opisthorchiasis.

Boonjaraspinyo S, Boonmars T, Aromdee C, Srisawangwong T, Kaewsamut B, Pinlaor S, Yongvanit P, Puapairoj A.

Parasitol Res. 2009 Oct;105(5):1459-63. doi: 10.1007/s00436-009-1553-3. Epub 2009 Jul 25.

PMID:
19633869
35.

Metabolic enzymes, antioxidants, and cytoskeletal proteins are significantly altered in vastus lateralis muscle of K-depleted cadaveric subjects.

Tavichakorntrakool R, Sriboonlue P, Prasongwattana V, Puapairoj A, Yenchitsomanus PT, Sinchaikul S, Chen ST, Wongkham C, Thongboonkerd V.

J Proteome Res. 2009 May;8(5):2586-93. doi: 10.1021/pr800941g.

PMID:
19245216
36.

Leptospira interrogans requires heme oxygenase for disease pathogenesis.

Murray GL, Srikram A, Henry R, Puapairoj A, Sermswan RW, Adler B.

Microbes Infect. 2009 Feb;11(2):311-4. doi: 10.1016/j.micinf.2008.11.014. Epub 2008 Dec 16.

PMID:
19114124
37.

Analyses of vaccination protocols for Leptospira interrogans serovar autumnalis in hamsters.

Srikram A, Wongratanacheewin S, Puapairoj A, Wuthiekanun V, Sermswan RW.

Am J Trop Med Hyg. 2008 Nov;79(5):779-86.

PMID:
18981522
38.

Serial analyses of postmortem changes in human skeletal muscle: A case study of alterations in proteome profile, histology, electrolyte contents, water composition, and enzyme activity.

Tavichakorntrakool R, Prasongwattana V, Sriboonlue P, Puapairoj A, Pongskul J, Khuntikeo N, Hanpanich W, Yenchitsomanus PT, Wongkham C, Thongboonkerd V.

Proteomics Clin Appl. 2008 Sep;2(9):1255-64. doi: 10.1002/prca.200800051. Epub 2008 Jul 30.

PMID:
21136921
39.

K+, Na+, Mg2+, Ca2+, and water contents in human skeletal muscle: correlations among these monovalent and divalent cations and their alterations in K+ -depleted subjects.

Tavichakorntrakool R, Prasongwattana V, Sriboonlue P, Puapairoj A, Wongkham C, Wiangsimma T, Khunkitti W, Triamjangarun S, Tanratanauijit M, Chamsuwan A, Khunkitti W, Yenchitsomanus PT, Thongboonkerd V.

Transl Res. 2007 Dec;150(6):357-66. Epub 2007 Sep 29.

PMID:
18022598
40.

Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.

Seubwai W, Wongkham C, Puapairoj A, Khuntikeo N, Wongkham S.

Cancer. 2007 Jun 15;109(12):2497-505.

41.

Pulmonary actinomycosis presenting with prolonged fever and massive hemoptysis: a case report.

Reechaipichitkul W, Napaprasit T, Puapairoj A, Prathanee S.

Southeast Asian J Trop Med Public Health. 2005 Sep;36(5):1268-71.

PMID:
16438156
42.

MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.

Boonla C, Sripa B, Thuwajit P, Cha-On U, Puapairoj A, Miwa M, Wongkham S.

World J Gastroenterol. 2005 Aug 28;11(32):4939-46.

43.

Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100).

Sripa B, Leungwattanawanit S, Nitta T, Wongkham C, Bhudhisawasdi V, Puapairoj A, Sripa C, Miwa M.

World J Gastroenterol. 2005 Jun 14;11(22):3392-7.

44.

Histology of gastritis and Helicobacter pylori infection in Thailand: a nationwide study of 3776 cases.

Atisook K, Kachinthorn U, Luengrojanakul P, Tanwandee T, Pakdirat P, Puapairoj A.

Helicobacter. 2003 Apr;8(2):132-41.

PMID:
12662381
45.

Bronchial adenoma presenting with chronic asthma and obstructive pneumonia: a case report.

Reechaipichitkul W, Saengsaard S, Puapairoj A, Boonsawat W.

Southeast Asian J Trop Med Public Health. 2002 Mar;33(1):164-9.

PMID:
12118446

Supplemental Content

Loading ...
Support Center